NDC 21922-002

Clindamycin Phoaphate Topical Solution USP, 1%

Clindamycin Phosphate Topical Solution Usp, 1%

Clindamycin Phoaphate Topical Solution USP, 1% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Encube Ethicals Private Limited. The primary component is Clindamycin Phosphate.

• Product ID: 21922-002_1955260c-d155-4fb7-a0bf-473a191c6287
• NDC: 21922-002
• Product Type: Human Prescription Drug
• Proprietary Name: Clindamycin Phoaphate Topical Solution USP, 1%
• Generic Name: Clindamycin Phosphate Topical Solution Usp, 1%
• Dosage Form: Solution
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-03-04
• Marketing Category: ANDA / ANDA
• Application Number: ANDA209914
• Labeler Name: Encube Ethicals Private Limited
• Substance Name: CLINDAMYCIN PHOSPHATE
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 21922-002-01

1 BOTTLE in 1 CARTON (21922-002-01) > 60 mL in 1 BOTTLE

• Marketing Start Date: 2019-03-04
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 21922-002-01 [21922000201]

Clindamycin Phoaphate Topical Solution USP, 1% SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA209914
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2019-03-04

Drug Details

Active Ingredients

Ingredient	Strength
CLINDAMYCIN PHOSPHATE	10 mg/mL

OpenFDA Data

• SPL SET ID: b2dfb76b-db09-43e7-8366-6791449a4918
• Manufacturer:
  • Encube Ethicals Private Limited
• UNII:
  • EH6D7113I8
• RxNorm Concept Unique ID - RxCUI:
  • 309333
• UPC Code:
  • 0321922002010

Pharmacological Class

• Decreased Sebaceous Gland Activity [PE]
• Lincosamide Antibacterial [EPC]
• Lincosamides [CS]